Boston Globe - October 24, 2006
The method most dialysis clinics use to give patients a critical anti-anemia drug may needlessly cost the federal government as much as $537 million annually while generating additional profits for its manufacturer and clinics. Read more...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment